{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:36:25Z","timestamp":1776688585286,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ajoc.2020.100706","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T02:27:35Z","timestamp":1588127255000},"page":"100706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A case of anti-VEGF therapy application in Takayasu arteries with retinopathy"],"prefix":"10.1016","volume":"19","author":[{"given":"Qiaoyun","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianwei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng'e","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7562-3603","authenticated-orcid":false,"given":"Weijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2020.100706_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajoc.2020.100706_bib2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/rheumatology\/kex075","article-title":"Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?","volume":"56","author":"Seeliger","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajoc.2020.100706_bib3","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.lpm.2017.05.034","article-title":"Epidemiology of Takayasu arteritis","volume":"46","author":"Onen","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.ajoc.2020.100706_bib4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/IAE.0b013e3181fe540b","article-title":"Ocular manifestations of Takayasu arteritis: a cross-sectional study","volume":"31","author":"Peter","year":"2011","journal-title":"Retina (Philadelphia, Pa)"},{"key":"10.1016\/j.ajoc.2020.100706_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00006982-200104000-00006","article-title":"The clinical and ocular manifestations of Takayasu arteritis","volume":"21","author":"Chun","year":"2001","journal-title":"Retina (Philadelphia, Pa)"},{"key":"10.1016\/j.ajoc.2020.100706_bib6","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1161\/CIRCULATIONAHA.107.759589","article-title":"Overview of late outcome of medical and surgical treatment for Takayasu arteritis","volume":"118","author":"Ogino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ajoc.2020.100706_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajo.2018.08.026","article-title":"Conbercept for treatment of neovascular age-related macular degeneration: results of the randomized phase 3 PHOENIX study","volume":"197","author":"Liu","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2020.100706_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1573399811666150615151324","article-title":"Anti-VEGF therapy for retinal vein occlusions","volume":"17","author":"Campa","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ajoc.2020.100706_bib9","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.ophtha.2016.07.010","article-title":"Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response","volume":"123","author":"Lee","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2020.100706_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10384-009-0650-2","article-title":"Takayasu disease on the centenary of its discovery","volume":"53","author":"Sugiyama","year":"2009","journal-title":"Jpn J Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620300657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620300657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:58:23Z","timestamp":1762527503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993620300657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":10,"alternative-id":["S2451993620300657"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100706","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of anti-VEGF therapy application in Takayasu arteries with retinopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100706"}}